Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Minoxidil can cause deadly skin reaction; monitor patients closely.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

COVID-19 can cause different skin issues, including rashes and hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

People with HIV and low T cell counts have more hair and scalp problems.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

The conclusion of the case is not provided in the summary.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.